Biobuild SRL
The score of Biobuild shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity -57 % Total assets -54 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Biobuild's annual accounts
Filed annual accounts
- Year ended 30 Jun 2025filed on 20 Feb 2026
- Year ended 30 Jun 2024filed on 20 Feb 2025
- Year ended 30 Jun 2023filed on 20 Feb 2024
- Year ended 30 Jun 2022filed on 08 Feb 2023
- Year ended 30 Jun 2021filed on 31 Mar 2022
Biobuild's financial analysis
- Solvency22.5%sector median: 41.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Biobuild
Biobuild's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0895.354.738
- VAT number
- BE0895354738
- Peppol
- Registered · 0208:0895354738 · as of 30 Oct 2026
- Legal form
- SRL
- Incorporated
- 30 Jan 2008
- Registered office
- 2030 Antwerp
- Latest accounts
- 2025 · filed on 20 Feb 2026
- Activity
- General construction of residential buildings (NACE 41001)
Biobuild (SRL) has been based in Antwerp since 2008, active in: general construction of residential buildings. For 2025, it reports a net profit of 6,889 € and equity of 74,589 €; its revenue is not published. Its solvency stands at 22.5%, below the median of its sector (41.8%).
Companies similar to Biobuild
Companies in the same business, of comparable size and area, outside its group.
- Van Rayen Construct Construction of residential and non-residential buildings Antwerp · balance sheet 76,058 €
- CRE-8 Construction of residential and non-residential buildings Knokke-Heist · balance sheet 400,963 €
- NAM Construction of residential and non-residential buildings Ghent · balance sheet 319,605 €
- Katov-Bouw Construction of residential and non-residential buildings Ghent · balance sheet 17,889 €
- MCC Construction of residential and non-residential buildings Brussels · balance sheet 352,267 €
- F.I. Construction of residential and non-residential buildings Antwerp · balance sheet 285,335 €
- Zlato Renovation Construction of residential and non-residential buildings Zaventem · balance sheet 214,134 €
- Amygo Construction of residential and non-residential buildings Meise · balance sheet 225,375 €
Frequently asked questions about Biobuild
What is the revenue of Biobuild?
Biobuild files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Biobuild?
In Belgium, the VAT number is the company number prefixed with BE: BE0895354738 for Biobuild, if the company is VAT-registered. Its company number (CBE) is 0895.354.738.
Where is the registered office of Biobuild?
According to the CBE register, the registered office of Biobuild is in 2030 Antwerp.
What is the equity of Biobuild?
At the close of the 2025 financial year, the equity of Biobuild amounts to 74,589 €, a solvency of 22.5% of total assets.
Who manages Biobuild?
The register lists 1 active mandates at Biobuild. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Biobuild
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →